TVRD - Cara Therapeutics, Inc.
3.93
-0.090 -2.290%
Share volume: 53,467
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$4.02
-0.09
-0.02%
Summary score
17%
Profitability
8%
Dept financing
5%
Liquidity
75%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.56%
Return on assets
-15.02%
Return on sales
-183.68%
Return on invested capital
40.51%
Total debt ratio
20.58%
Debt ratio change over timeo
0%
Current Ratio
6.71%
Quick Ratio
8%
Cash Position Ratio
1.42%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.01%
Return on assets
-13.77%
Return on sales
-183.68%
Return on invested capital
-190.98%
Total debt ratio
16.89%
Debt ratio change over timeo
0%
Current Ratio
5.42%
Quick Ratio
8%
Cash Position Ratio
2.63%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-12.91%
Return on assets
-11.57%
Return on sales
-183.68%
Return on invested capital
718.09%
Total debt ratio
13.11%
Debt ratio change over time
0%
Current Ratio
8%
Quick Ratio
8%
Cash Position Ratio
7.28%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TVRD | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -18.56% | 18.71% | 4.67% | -3.65% |
| Return on assets | -15.02% | 3.4% | 3.32% | 3.5% |
| Return on sales | -183.68% | 24.27% | 25.81% | 31.31% |
| Return on invested capital | 40.51% | 5.38% | 4.17% | 4.99% |
| Profitability | 25% | 72% | 53% | 53% |
| Total debt ratio | 20.58% | 78.91% | 58.54% | 101.15% |
| Debt ratio change over time | 0% | 0% | 10.69% | 52.18% |
| Dept financing | 5% | 20% | 20% | 50% |
| Current Ratio | 5.42% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 8% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 2.63% | 0.21% | 0.6% | 1.41% |
| Liquididy | 75% | 14% | 20% | 22% |
| Short-term ratios | TVRD | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -16.01% | 41.05% | 6.87% | -16.17% |
| Return on assets | -13.77% | 3.67% | 3.13% | 2.71% |
| Return on sales | -183.68% | 26.16% | 24.75% | 29.9% |
| Return on invested capital | -190.98% | 9.43% | 5.58% | 6.54% |
| Profitability | 0% | 97% | 61% | 61% |
| Total debt ratio | 16.89% | 91.28% | 61.3% | 99.31% |
| Debt ratio change over time | 0% | 0% | 13.89% | -24.55% |
| Dept financing | 4% | 23% | 40% | 25% |
| Current Ratio | 5.42% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 8% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 2.63% | 0.21% | 0.6% | 1.41% |
| Liquididy | 75% | 11% | 15% | 29% |